UniQuest
June 23, 2026
Theater 1
Type: Company Presentation
Focus Area:
Cardiovascular
UniQuest is commercializing First‑in‑Class Troponin Modulator for the treatment of HFpEF.
Company HQ City:
Brisbane
Company HQ State:
Queensland
Company HQ Country:
Australia
Year Founded:
1984
Lead Product in Development:
NA
CEO
Dr Dean Moss, CEO
Development Phase of Lead Product
Discovery
When you expect your next catalyst update?
NA
What is your next catalyst (value inflection) update?
NA
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}